🚨New Project Publication! 🚨
A new publication by the #EDCTP-funded #GenPathAfrica consortium develops a new sequencing protocol for sequencing #HBV, which could significantly enhance diagnosis, treatment, and surveillance of the virus.
Read more ➡️https://t.co/iCeBzrfwiv
#WORMVACS annual meeting is in Berlin this week!
On the agenda: project progress reports & planning of upcoming activities in the work on vaccines against #helminth infections.
More project info: https://t.co/bacMlWAf8E
@HorizonEU@EU_HaDEA#NeglectedTropicalDiseases
🚨New Project Publication! 🚨
In a new Science article, #GenPathAfrica coordinator Tulio de Oliveira introduces the “third era” of #genomics and discusses the field’s history and the threats it may be facing in the future.
Want to learn more? 👉 https://t.co/dEaXaecsxM
🚨New Project Publication! 🚨
In a new study, the #EDCTP-funded #GenPathAfrica consortium used advanced #genomicsequencing techniques to investigate previously unidentified mycobacteria species in TB-infected sites outside the lungs.
Read more ➡️https://t.co/eMyl1J67OS
🚨New Project Publication! 🚨
In a new paper, the #EDCTP-funded #GenPathAfrica consortium provides a genomic retrospective study on Rift Valley Fever outbreaks in Rwanda.
Read more ➡️ https://t.co/AP7wG7ZHH9
🚨New Project Publication!🚨
The #EDCTP-funded MARC SE-Africa consortium calls on all African countries in which #malaria is endemic to develop & implement a detailed action plan to counter #artemisinin partial resistance.
Read more➡️ https://t.co/R8DF8Fr3an
We're happy to share a new funding opportunity from one of our projects, the IMPRINT Network, which focuses on maternal and neonatal #immunisation!
Learn more about the network and our call for new Visiting Fellowships👉 https://t.co/YslXWqQFKF
🚨Call for Applications!🚨
IMPRINT's Visiting Fellowships will enable network members to gain work experience in industry, laboratories or clinical trial units. Application deadline is 24 November 2024, 4pm GMT!
Learn more 👉https://t.co/bPRUuG3PZz
🚨New Project Publication!🚨
#EDCTP-funded TB-CAPT consortium published the findings of the EXULTANT trial in Tanzania and Mozambique, exploring a new diagnostic strategy (enhanced TB screening) for hospitalised people living with HIV.
Read more ➡️https://t.co/c9MU8QFyOy
Paper: "Insights into mycobacteriome composition in Mycobacterium bovis-infected African buffalo (Syncerus caffer) tissue samples"
By: @G_Ghielmetti, Tanya J. Kerr, Netanya Bernitz, Sinegugu K. Mhlophe, Elizma Streicher, @AGLoxton, Robin M. Warren, Michele A. Miller, @drwjgoosen
🚨 New Project Publication! 🚨
In a new study from our #EDCTP3-funded #GenPathAfrica Consortium, scientists developed a new method to characterize the mycobacteria present in #TB-infected tissue samples!
Want to learn more? 👉https://t.co/CSo2r9RsEZ
🚨 New Project Publications! 🚨
Two recent studies from our #EDCTP3-funded #GenPathAfrica Consortium show that advanced genomic testing and analysis are powerful tools in the fight against #TB in rural South Africa.
Learn more: https://t.co/w9gRhuw8Zg
🚀 Kick-off of #GlobalHealthEDCTP3 funded project #PROTECT 1st Annual Meeting!
📍 Location: Uganda
📅 Dates: June 10-12
To know more about PROTECT, and its partners, click below to access our projects page 👇
🔗 https://t.co/4ogGbuktoj
Last week, the @EDCTP3 funded #GenPathAfrica project held its first annual meeting at @StellenboschUni. It was a great opportunity to reflect on progress made together in advancing genomic epidemiology in Africa!
Read more 👉https://t.co/j93JOC5OGX
Advancing genomic epidemiology in Africa, the #GenPathAfrica workshop kicks off today at BMRI, @StellenboschUni, South Africa! From May 27-28, this annual meeting has brought together key researchers and collaborators for the first time face-to-face. #Genomics#PublicHealth
Congratulations from the entire LINQ team to Prof. @Tuliodna for this special recognition👏 We are excited to continue to work together to strengthen #genomicsurveillance in Africa and beyond!
Exciting News! @TIME's 2024 #TIME100Health list is out! Proud to announce Prof. @Tuliodna's selection! His second recognition underscores his ongoing impact in global health. Check out the full list at https://t.co/qldIU99kyL
📢Attention researchers 📢use the freely available #malaria clinical trials toolkit to design and run your clinical trial. Access resources for each stage in a step-by-step guide 👉https://t.co/0pcSI8BDk0